Balaji Amines

Who are the top shareholders of the Balaji Amines?

The top shareholders of Balaji Amines include promoter Ande Prathap Reddy with 15.34%, individual investors with 34.47%, 94 Foreign Institutional Investors holding 5.08%, and mutual funds with 0.13%. The highest public shareholder is Vineel Reddy Nalla at 2.13%.

The top shareholders of Balaji Amines include the promoters, who hold the majority of the shares. The promoter with the highest holding is Ande Prathap Reddy, who owns 15.34% of the company. Additionally, individual investors collectively hold 34.47% of the shares. In terms of institutional investors, 94 Foreign Institutional Investors (FIIs) hold 5.08% of the company, while mutual funds are represented by 11 schemes, holding a combined 0.13%. The highest public shareholder is Vineel Reddy Nalla, with a holding of 2.13%.

Who are in the management team of Balaji Amines?

As of March 2023, the management team of Balaji Amines includes A Prathap Reddy (Executive Chairman), N Rajeshwar Reddy (Joint Managing Director), D Ram Reddy (Managing Director), A Srinivas Reddy (Whole Time Director & CFO), and several independent directors. They are responsible for the company's governance and strategic direction.

As of March 2023, the management team of Balaji Amines includes the following members:<BR><BR>1. A Prathap Reddy - Executive Chairman<BR>2. N Rajeshwar Reddy - Joint Managing Director<BR>3. D Ram Reddy - Managing Director<BR>4. A Srinivas Reddy - Whole Time Director & CFO<BR>5. Lakhan Suganchand Dargad - Company Secretary & Compliance Officer<BR>6. Suhasini Y Shah - Independent Director<BR>7. Adabala Seshagiri Rao - Independent Director<BR>8. Uma Rajiv Pradhan - Independent Director<BR>9. R. Mohan Kumar - Independent Director<BR><BR>These individuals play key roles in the governance and strategic direction of the company.

What does Balaji Amines do?

Balaji Amines Ltd is a small-cap manufacturer of ethyl and methyl amines in the specialty chemicals sector, with a market cap of Rs 4,790 Cr and reported net sales of 353 Cr and net profit of 40 Cr for the quarter ending March 2025. The company was incorporated in 1988 and has key financial metrics including a P/E ratio of 30.00 and a dividend yield of 0.75%.

Overview:<BR>Balaji Amines Ltd is a leading manufacturer of ethyl and methyl amines, operating within the specialty chemicals industry and categorized as a small-cap company.<BR><BR>History:<BR>Incorporated on 27th October 1988, Balaji Amines Ltd has maintained its status as a key player in the specialty chemicals sector. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 353 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 40 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 4,790 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 30.00<BR>- Industry P/E: 47<BR>- Dividend Yield: 0.75%<BR>- Debt Equity: -0.19<BR>- Return on Equity: 8.54%<BR>- Price to Book: 2.58<BR><BR>Contact Details:<BR>Address: Balaji Towers No 9/1A/1, Hotgi Road Aasara Chowk Solapur Maharashtra : 413224<BR>Tel: 91-217-2310824<BR>Email: cs@balajiamines.com<BR>Website: http://www.balajiamines.com

What is the bonus history of the Balaji Amines?

Balaji Amines has a bonus history that includes a 1:1 bonus issue announced on March 5, 2007, with a record date of March 6, 2007, allowing shareholders to receive one additional share for each share owned.

Balaji Amines has a bonus history that includes a notable 1:1 bonus issue. This was announced with an ex-date of March 5, 2007, and the record date was March 6, 2007. This means that shareholders received one additional share for every share they owned as of the record date. If you have any more questions about Balaji Amines or need further details, feel free to ask!

Has Balaji Amines declared dividend?

Yes, Balaji Amines Ltd has declared a 550% dividend, amounting to ₹11 per share, with an ex-date of July 4, 2024. Despite this significant dividend, recent total returns have been negative over shorter periods, though the company has shown strong recovery with a positive total return of 276.15% over the past five years.

Balaji Amines Ltd has declared a 550% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 550%<BR>- Amount per share: 11<BR>- Ex-date: 04 Jul 24<BR><BR>Dividend Yield: 0.75%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -29.07%, with a dividend return of 0%, resulting in a total return of -29.07%.<BR><BR>Over the past year, the price return was -30.81%, with a dividend return of 0.50%, leading to a total return of -30.31%.<BR><BR>In the 2-year period, the price return was -32.27%, the dividend return was 0.89%, and the total return was -31.38%.<BR><BR>For the 3-year period, the price return was -53.34%, the dividend return was 0.75%, resulting in a total return of -52.59%.<BR><BR>In the last 4 years, the price return was -45.52%, with a dividend return of 1.15%, leading to a total return of -44.37%.<BR><BR>Finally, over the past 5 years, the price return was 270.22%, the dividend return was 5.93%, resulting in a total return of 276.15%.<BR><BR>Overall, while Balaji Amines has declared a significant dividend, the recent total returns indicate a challenging performance, particularly over shorter periods, with substantial losses in price returns. However, the long-term return over five years shows a strong recovery with positive total returns.

Who are the peers of the Balaji Amines?

Peers of Balaji Amines include Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Neogen Chemicals, Camlin Fine, Rossari Biotech, and Vishnu Chemicals. Balaji Amines has below-average growth and management risk, with a 1-year return of -28.68%, significantly lower than Camlin Fine's 163.83%.

Peers: The peers of Balaji Amines are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Neogen Chemicals, Camlin Fine, Rossari Biotech, and Vishnu Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at Pidilite Inds., SRF, Deepak Nitrite, Neogen Chemicals, Rossari Biotech, and Vishnu Chemicals, while Average management risk is found at Gujarat Fluoroch, Himadri Special, Balaji Amines, and S H Kelkar & Co. Below Average management risk is noted at Camlin Fine. Growth is Average for Pidilite Inds., SRF, and Rossari Biotech, while Good growth is seen at Himadri Special and Vishnu Chemicals. Balaji Amines, Gujarat Fluoroch, Deepak Nitrite, Neogen Chemicals, Camlin Fine, and S H Kelkar & Co. exhibit Below Average growth, and the rest show Below Average growth. Capital Structure is Excellent for Pidilite Inds., SRF, Deepak Nitrite, Balaji Amines, and Rossari Biotech, while Good capital structure is found at Gujarat Fluoroch, Himadri Special, and S H Kelkar & Co. Average capital structure is observed at Vishnu Chemicals, and Below Average at Neogen Chemicals and Camlin Fine.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Camlin Fine at 163.83%, while Balaji Amines has the lowest at -28.68%. This indicates that Balaji Amines' 1-year return is significantly lower than that of Camlin Fine. Additionally, Deepak Nitrite, Balaji Amines, and Rossari Biotech have negative six-month returns.

How big is Balaji Amines?

As of 24th July, Balaji Amines Ltd has a market capitalization of 5,637.00 Cr, with recent Net Sales of 1,397.09 Cr and a Net Profit of 157.52 Cr. The company has Shareholder's Funds of 1,845.06 Cr and Total Assets of 2,252.06 Cr.

As of 24th July, Balaji Amines Ltd has a market capitalization of 5,637.00 Cr, categorizing it as a Mid Cap company.<BR><BR>In the latest four quarters, Balaji Amines reported Net Sales of 1,397.09 Cr and a Net Profit of 157.52 Cr.<BR><BR>For the latest annual period ending March 2025, the company has Shareholder's Funds amounting to 1,845.06 Cr and Total Assets of 2,252.06 Cr.

Is Balaji Amines technically bullish or bearish?

As of November 7, 2025, Balaji Amines is in a bearish trend with moderate strength, indicated by bearish MACD, Bollinger Bands, and KST signals, despite mixed short-term momentum from the RSI.

As of 7 November 2025, the technical trend for Balaji Amines has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly timeframe, bearish signals from Bollinger Bands and KST on both weekly and monthly timeframes, and a bearish moving average on the daily chart. The RSI shows bullish momentum on the weekly but lacks a clear signal on the monthly, indicating mixed signals in the short term. Overall, the bearish trend is reinforced by the recent price action, with the stock down from its previous close.

How has been the historical performance of Balaji Amines?

Balaji Amines has experienced a decline in net sales, operating income, and profits from March 2023 to March 2025, with net profit dropping from INR 405.68 crore to INR 158.59 crore, despite an increase in total assets and liabilities. Cash flow from operating activities also decreased, although net cash inflow improved in March 2025.

Answer:<BR>The historical performance of Balaji Amines shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Balaji Amines' net sales have seen a decline from INR 2,355.40 crore in March 2023 to INR 1,397.08 crore in March 2025. This downward trend is mirrored in total operating income, which also decreased from INR 2,355.40 crore in March 2023 to INR 1,397.08 crore in March 2025. The company’s total expenditure has similarly dropped from INR 1,746.29 crore in March 2023 to INR 1,164.93 crore in March 2025. Operating profit (PBDIT) has followed a similar pattern, decreasing from INR 624.36 crore in March 2023 to INR 265.35 crore in March 2025. Consequently, profit before tax has also declined from INR 566.82 crore in March 2023 to INR 213.22 crore in March 2025, leading to a profit after tax of INR 158.59 crore in March 2025, down from INR 405.68 crore in March 2023. The company's total assets increased from INR 1,962.81 crore in March 2023 to INR 2,252.06 crore in March 2025, while total liabilities rose from INR 1,962.81 crore to INR 2,252.06 crore in the same period. Cash flow from operating activities has decreased from INR 353.00 crore in March 2023 to INR 255.00 crore in March 2025, although the net cash inflow improved to INR 67.00 crore in March 2025 from a net outflow of INR 15.00 crore in March 2024. Overall, Balaji Amines has experienced significant fluctuations in its financial performance, with notable declines in sales and profits, despite an increase in total assets and liabilities.

How has been the historical performance of Balaji Amines?

Balaji Amines has experienced a decline in net sales, operating income, and profits from March 2023 to March 2025, with profit after tax dropping from INR 405.68 crore to INR 158.59 crore. However, the company's total assets have increased, indicating a complex financial situation despite the revenue and profit downturn.

Answer:<BR>The historical performance of Balaji Amines shows a fluctuating trend in its financial metrics over the years.<BR><BR>Breakdown:<BR>Balaji Amines' net sales have seen a decline from INR 2,355.40 crore in March 2023 to INR 1,397.08 crore in March 2025. This downward trend is mirrored in total operating income, which dropped from INR 2,355.40 crore in March 2023 to INR 1,397.08 crore in March 2025. The company's total expenditure also decreased, from INR 1,746.29 crore in March 2023 to INR 1,164.93 crore in March 2025, contributing to a decline in operating profit from INR 609.11 crore to INR 232.15 crore during the same period. Profit before tax followed a similar pattern, decreasing from INR 566.82 crore in March 2023 to INR 213.22 crore in March 2025. Consequently, profit after tax also fell from INR 405.68 crore to INR 158.59 crore. Despite these declines, the company has shown resilience in its balance sheet, with total assets increasing from INR 1,962.81 crore in March 2023 to INR 2,252.06 crore in March 2025, while total liabilities rose from INR 1,962.81 crore to INR 2,252.06 crore. Cash flow from operating activities has remained positive, although it decreased from INR 353.00 crore in March 2023 to INR 255.00 crore in March 2025. Overall, Balaji Amines has experienced significant revenue and profit declines, yet its asset base has expanded, indicating a complex financial landscape.

Is Balaji Amines overvalued or undervalued?

As of November 12, 2025, Balaji Amines is considered very expensive and overvalued with a PE ratio of 28.28, despite being lower than some peers, and has underperformed with a year-to-date return of -28.55% compared to the Sensex's 8.10% gain.

As of 12 November 2025, the valuation grade for Balaji Amines has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently considered overvalued based on its financial metrics, with a PE ratio of 28.28, an EV to EBITDA of 18.05, and a Price to Book Value of 2.19. <BR><BR>In comparison to its peers, Balaji Amines' PE ratio is notably lower than Solar Industries at 96.33 and Gujarat Fluoroch at 59.55, both of which are also classified as very expensive. However, it is higher than Godrej Industries, which is rated attractive with a PE of 37.28. The company's recent stock performance has been poor, with a year-to-date return of -28.55%, contrasting sharply with the Sensex's gain of 8.10% over the same period, reinforcing the view that Balaji Amines is currently overvalued.

Are Balaji Amines Ltd latest results good or bad?

Balaji Amines Ltd's latest results are poor, showing a 9.05% decline in net profit quarter-on-quarter and a 15.67% drop year-on-year, alongside decreased net sales and deteriorating return ratios, reflecting ongoing challenges in the specialty chemicals sector.

Balaji Amines Ltd's latest results indicate a challenging performance. In Q3 FY26, the company reported a consolidated net profit of ₹34.56 crore, which represents a decline of 9.05% quarter-on-quarter and 15.67% year-on-year. Net sales also decreased by 4.96% sequentially and 1.82% compared to the same quarter last year, totaling ₹340.55 crore.<BR><BR>While there was a slight improvement in operating margins, which rose to 17.56% from 15.26% in the previous quarter, this figure remains significantly lower than the 23.60% achieved in March 2024. The overall financial performance reflects ongoing struggles with demand in the specialty chemicals sector, leading to weak volume traction and margin pressures.<BR><BR>Additionally, the company's stock has faced substantial declines, down nearly 31% over the past year, significantly underperforming compared to the broader market. The return ratios have also deteriorated, with Return on Capital Employed (ROCE) dropping to 10.39%, well below historical averages.<BR><BR>In summary, the latest results can be characterized as poor, with multiple indicators pointing to operational challenges and declining profitability.

When is the next results date for Balaji Amines Ltd?

The next results date for Balaji Amines Ltd is 13 May 2026.

The next results date for Balaji Amines Ltd is scheduled for 13 May 2026.

Should I buy, sell or hold Balaji Amines Ltd?

Which are the latest news on Balaji Amines?

Why is Balaji Amines Ltd falling/rising?

As of 09-May, Balaji Amines Ltd's stock price is declining by 2.55% after a trend reversal, underperforming its sector and showing significant long-term growth concerns. The company has reported negative results for seven consecutive quarters, and investor interest is waning, contributing to the stock's current downward movement.

As of 09-May, Balaji Amines Ltd's stock price is currently falling, with a change of -38.9 points, representing a decrease of 2.55%. This decline follows a trend reversal after five consecutive days of gains. The stock has underperformed its sector by 2.73% today and reached an intraday low of Rs 1481.85, which is a decrease of 2.75% from the previous price.<BR><BR>Despite the stock's strong performance over the past year, generating a return of 19.55% compared to the market's average return of 5.38%, there are significant concerns regarding the company's long-term growth. The operating profit has declined at an annual rate of -7.83% over the last five years, and the company has reported negative results for the last seven consecutive quarters. Additionally, the return on capital employed (ROCE) is at its lowest at 10.39%, and the profit after tax (PAT) for the last quarter has fallen by 13.8% compared to the previous four-quarter average.<BR><BR>Investor participation is also waning, with delivery volume decreasing by 11.72% against the five-day average, indicating reduced interest in the stock. Furthermore, the stock is trading at a premium valuation with a price-to-book value of 2.6, which is considered very expensive compared to its peers. This combination of poor long-term growth prospects, declining profits, and reduced investor participation contributes to the current downward movement in Balaji Amines Ltd's stock price.